State of Wyoming’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-991
Closed -$29.7K 2048
2026
Q1
$29.7K Sell
991
-236
-19% -$7.81K ﹤0.01% 1634
2025
Q4
$40.1K Buy
1,227
+271
+28% +$8.75K ﹤0.01% 1594
2025
Q3
$33.1K Sell
956
-62
-6% -$1.98K ﹤0.01% 1646
2025
Q2
$28.5K Buy
+1,018
New +$27.3K ﹤0.01% 1671
2022
Q3
Sell
-83
Closed -$5K 1676
2022
Q2
$5K Buy
+83
New +$4.92K ﹤0.01% 1717
2021
Q3
Sell
-1
Closed 1258
2021
Q2
$0 Hold
1
﹤0.01% 1185
2021
Q1
$0 Buy
+1
New +$92 ﹤0.01% 518

Other funds holding LKFT

State of Wyoming's LKFT Position: Q2 2026 in Review

State of Wyoming sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q2 2026, closing a stake of 991 shares — an estimated $29.7K sold.

State of Wyoming first reported a position in LKFT in Q1 2021 and held it in 7 quarters. The position peaked at $40.1K in Q4 2025. 24 funds tracked by Wall St. Rank hold LKFT as of Q2 2026.

  • State of Wyoming reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q2 2026 after selling out during the quarter.
  • State of Wyoming sold 991 Lakefront Biotherapeutics American Depositary Shares shares in Q2 2026, an estimated $29.7K.
  • State of Wyoming first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q1 2021 and held it in 7 quarters.
  • State of Wyoming's Lakefront Biotherapeutics American Depositary Shares position peaked at $40.1K in Q4 2025.
  • 24 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q2 2026.

Based on State of Wyoming's 13F filing for Q2 2026, filed 6 Aug 2026.